ClinicalTrials.Veeva

Menu

Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock

M

Mongi Slim Hospital

Status

Unknown

Conditions

Trans Cranial Doppler Ultrasonography in Heamodynamic Optimisation in Septic Shock

Treatments

Procedure: hemodynamic optimisation aiming to achieve normal cerebral perfusion

Study type

Interventional

Funder types

Other

Identifiers

NCT04398069
Hemodynamic optimization ICU

Details and patient eligibility

About

Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic Shock, at the early phase.

patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin doses:

  • Group 1: standard hemodynamic goals and catecholamin infusion to achieve: mean arterial pressure > or equal to 65 mmHg and diastolic arterial pressure > ou equal to 50 mmHg within the first 60 minutes.
  • Group 2: personalized hemodynamic goals and catecholamin infusion until normal transcranial doppler: IP<1,2.

Full description

Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic Shock, at the early phase.

patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin doses:

  • Group 1: standard hemodynamic goals and cathecolamin infusion to achieve: mean arterial pressure > or equal to 65 mmHg and diastolic arterial pressure > ou equal to 50 mmHg within the first 60 minutes.
  • Group 2: personalized hemodynamic goals and cathecolamin infusion until normal transcranial doppler: IP<1,2.

For the 2 groups, standard management including: microbiological sampling, early broad spectrum anti infective therapy, fluid management and decreasing of blood lactate levels, will be aimed within the first 60 minutes.

For the Group 2 patients: personalized hemodynamic management will be maintained during 72 hours.

Enrollment

24 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All ICU patients presenting septic shock
  • No criteria of traumatic or vascular brain injury

Exclusion criteria

  • Patients with refractory septick shock
  • rapid fatal evolution: before 72 hours
  • No individualisation of the MCA ultrasonographic window

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Standard Group
No Intervention group
Description:
standard hemodynamic goals and catecholamin infusion to achieve: mean arterial pressure \> or equal to 65 mmHg and diastolic arterial pressure \> ou equal to 50 mmHg within the first 60 minutes.
personalized hemodynamic goals Group
Experimental group
Description:
Personalized hemodynamic goals and catecholamin infusion to achieve normal cerebral perfusion assessed by transcranial doppler: PI \< 1,2.
Treatment:
Procedure: hemodynamic optimisation aiming to achieve normal cerebral perfusion

Trial contacts and locations

1

Loading...

Central trial contact

Mhamed Sami Mebazaa, professor; Asma Ben Souissi, Ass Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems